>
WEBINAR

The Impact of MDR transition period extensions

Replay

Listen to a discussion of the recent extension to the MDR transition periods. It is important to understand what this means - and doesn't mean - for medtech companies marketing medical devices in the EU. Learn why this extension does not mean MDR certification should be delayed! Our panelists will include Rimsys experts - James Gianoutsos, founder and CEO; Bruce McKean, Director of Regulatory; and Adam Price, Director of Product for Post-Market.

More infoWatch ReplayGet the ebookGet the briefGet the case studyGet the data sheetGet the webinarGet the video
The Impact of MDR transition period extensions

Get the ebook

Get the case study

Get the webinar

Watch the replay!

Get the video

Get the data sheet

Thank you! Here's a link to your resource. We've also sent a copy to your inbox. Enjoy!
Thank you! We've sent you you details about accessing this event. If you do not receive an email in the next few minutes, please check your spam folder. Enjoy!
Download
Here's some additional content you may find helpful
A primer on medical device classification
A primer on medical device classification
 Introducing Rimsys Intel: A Free, Centralized Global Regulatory Intelligence Hub for Medtech
Introducing Rimsys Intel: A Free, Centralized Global Regulatory Intelligence Hub for Medtech
5 ways a RIM system can accelerate time-to-market for MedTech companies
5 ways a RIM system can accelerate time-to-market for MedTech companies
Here's your video, enjoy!
Check out these additional resources
Quick reference guide - global medical device UDI requirements and timelines
Quick reference guide - global medical device UDI requirements and timelines
A primer on medical device classification
A primer on medical device classification
5 ways a RIM system can accelerate time-to-market for MedTech companies
5 ways a RIM system can accelerate time-to-market for MedTech companies
Oops! Something went wrong while submitting the form